Bank of New York Mellon
DERM icon

Bank of New York Mellon’s Journey Medical DERM Stock Holding History

Bank of New York Mellon’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,195
Closed -$174K – 4320
2026
Q1 		$174K Buy
37,195
+8,457
+29% +$65.7K ﹤0.01% 4031
2025
Q4 		$222K Buy
28,738
+4,246
+17% +$33.3K ﹤0.01% 3983
2025
Q3 		$174K Sell
24,492
-374
-2% -$2.71K ﹤0.01% 4047
2025
Q2 		$179K Buy
+24,866
New +$172K ﹤0.01% 4017

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return

Bank of New York Mellon's DERM Position: Q2 2026 in Review

Bank of New York Mellon sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 37,195 shares — an estimated $174K sold.

Bank of New York Mellon first reported a position in DERM in Q2 2025 and held it in 4 quarters. The position peaked at $222K in Q4 2025. 23 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Bank of New York Mellon reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 37,195 Journey Medical shares in Q2 2026, an estimated $174K.
  • Bank of New York Mellon first reported a position in Journey Medical in Q2 2025 and held it in 4 quarters.
  • Bank of New York Mellon's Journey Medical position peaked at $222K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.